Abstract
1. The effect of subtherapeutic doses of warfarin on the activities of the four vitamin K-dependent clotting factors was studied at steady state in five patients each of whom had completed a therapeutic course of anticoagulation. 2. The four clotting factor activities were shown to be depressed to a similar extent for a given dose of warfarin. 3. The prothrombin complex activity was significantly lower than that of any of the clotting factors.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BIGGS R., DENSON K. W. THE FATE OF PROTHROMBIN AND FACTORS VIII, IX AND X TRANSFUSED TO PATIENTS DEFICIENT IN THESE FACTORS. Br J Haematol. 1963 Oct;9:532–547. doi: 10.1111/j.1365-2141.1963.tb05478.x. [DOI] [PubMed] [Google Scholar]
- BORCHGREVINK C. F., EGEBERG O., POOL J. G., SKULASON T., STORMORKEN H., WAALER B. A study of a case of congenital hypoprothrombinaemia. Br J Haematol. 1959 Jul;5:294–301. doi: 10.1111/j.1365-2141.1959.tb04037.x. [DOI] [PubMed] [Google Scholar]
- Breckenridge A. M. Interindividual differences in the response to oral anticoagulants. Drugs. 1977 Nov;14(5):367–375. doi: 10.2165/00003495-197714050-00003. [DOI] [PubMed] [Google Scholar]
- Denson K. W. The levels of factors II, VII, IX and X by antibody neutralization techniques in the plasma of patients receiving phenindione therapy. Br J Haematol. 1971 Jun;20(6):643–648. doi: 10.1111/j.1365-2141.1971.tb00803.x. [DOI] [PubMed] [Google Scholar]
- HJORT P. F., EGEBERG O., MIKKELSEN S. Turnover of prothrombin, factor VII and factor IX in a patient with hemophilia A. Scand J Clin Lab Invest. 1961;13:668–672. doi: 10.3109/00365516109137342. [DOI] [PubMed] [Google Scholar]
- Holford N. H. Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship. Clin Pharmacokinet. 1986 Nov-Dec;11(6):483–504. doi: 10.2165/00003088-198611060-00005. [DOI] [PubMed] [Google Scholar]
- Holford N. H., Sheiner L. B. Kinetics of pharmacologic response. Pharmacol Ther. 1982;16(2):143–166. doi: 10.1016/0163-7258(82)90051-1. [DOI] [PubMed] [Google Scholar]
- KAZMIER F., SPITTELL J. A., Jr, THOMPSON J. J., Jr, OWEN C. A., Jr EFFECT OF ORAL ANTICOAGULANTS ON FACTORS VII, IX, X, AND II. Arch Intern Med. 1965 Jun;115:667–673. doi: 10.1001/archinte.1960.03860180039007. [DOI] [PubMed] [Google Scholar]
- Kaiser D. G., Martin R. S. GLC determination of warfarin in human plasma. J Pharm Sci. 1974 Oct;63(10):1579–1581. doi: 10.1002/jps.2600631018. [DOI] [PubMed] [Google Scholar]
- LOELIGER E. A., HENSEN A., MATTERN M. J., HEMKER H. C. BEHAVIOUR OF FACTORS II, VII, IX AND X IN BLEEDING COMPLICATIONS DURING LONG-TERM TREATMENT WITH COUMARIN. Thromb Diath Haemorrh. 1964 Jan 1;10:278–281. [PubMed] [Google Scholar]
- LOELIGER E. A., HENSEN A. Substitution therapy in haemophilia B. Thromb Diath Haemorrh. 1961 Dec 15;6:391–410. [PubMed] [Google Scholar]
- LOELIGER E. A., van der ESCH, ter HAAR C., ROMENY WACHTER, BOOIJ H. L. Factor VII; its turnover rate and its possible role in thrombogenesis. Thromb Diath Haemorrh. 1960 Mar 1;4:196–200. [PubMed] [Google Scholar]
- Serlin M. J., Mossman S., Sibeon R. G., Tempero K. F., Breckenridge A. M. Interaction between diflunisal and warfarin. Clin Pharmacol Ther. 1980 Oct;28(4):493–498. doi: 10.1038/clpt.1980.193. [DOI] [PubMed] [Google Scholar]
- Serlin M. J., Sibeon R. G., Mossman S., Breckenridge A. M., Williams J. R., Atwood J. L., Willoughby J. M. Cimetidine: interaction with oral anticoagulants in man. Lancet. 1979 Aug 18;2(8138):317–319. doi: 10.1016/s0140-6736(79)90340-4. [DOI] [PubMed] [Google Scholar]
- Suttie J. W. Mechanism of action of vitamin K: synthesis of gamma-carboxyglutamic acid. CRC Crit Rev Biochem. 1980;8(2):191–223. doi: 10.3109/10409238009105469. [DOI] [PubMed] [Google Scholar]
